The Leadership Team at Aldeyra Therapeutics is responsible for guiding the company's strategic direction and overseeing the development and commercialization of innovative treatments for aldehyde toxicity-related diseases. This multidisciplinary team, comprising executives from commercial development, clinical and regulatory affairs, and technical operations, collaborates to ensure effective execution of the company's mission, while aligning research initiatives with market needs and regulatory requirements.
Christopher Pearson
Vice President, Commercial Dev...
David B. McMullin
Chief Commercial Officer
David J. Clark
Chief Medical Officer
David Noskowitz
Vice President, Regulatory Aff...
Lise L. Kjems
Vice President, Clinical Devel...
Stephen G. Machatha
Senior Vice President, Technic...
Todd C. Brady
CEO & President
View all